RECRUITING

Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

Conditions

Intimate Partner Violence Child Maltreatment

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.

Official Title

Examining Therapeutic Change Mechanisms in an Affect Regulation, Father-Focused Intervention for Reducing Family Violence and Associated Symptoms in Children

Quick Facts

Study Start:2024-01-11

Study Completion:2028-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06074068

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* have at least one 6 month to 12-year-old biological child with whom they have contact; * had an incident of IPV within the last 12 months prior to screening with their child's mother (based on court/police records, coparent or self-report); * have a currently open or recently investigated (in the last 6 months) case with CT DCF * are able to complete assessments in English; * agree to have their female coparents (mother of target child) contacted as collateral informants and for consent for participation of their child. If a participant has more than one child in the age range, the youngest will be selected; * female coparents (i.e., biological mother who need not be in a relationship with the father) consents to (at minimum) provide parent-report on child; however, may opt out of child participation. If the coparent agrees to participate by providing caregiver-report on child symptoms, but declines participation of their shared child, the father may still participate in the study if he meets eligibility criteria outlined below; thus, preventing any possible retaliation against co-parents for not consenting to child participation.	Pregnancy or breastfeeding Severe psychiatric disorders Active substance abuse Unstable medical conditions Inability to comply with study requirements

Inclusion Criteria

Exclusion Criteria

* have at least one 6 month to 12-year-old biological child with whom they have contact;
* had an incident of IPV within the last 12 months prior to screening with their child's mother (based on court/police records, coparent or self-report);
* have a currently open or recently investigated (in the last 6 months) case with CT DCF
* are able to complete assessments in English;
* agree to have their female coparents (mother of target child) contacted as collateral informants and for consent for participation of their child. If a participant has more than one child in the age range, the youngest will be selected;
* female coparents (i.e., biological mother who need not be in a relationship with the father) consents to (at minimum) provide parent-report on child; however, may opt out of child participation. If the coparent agrees to participate by providing caregiver-report on child symptoms, but declines participation of their shared child, the father may still participate in the study if he meets eligibility criteria outlined below; thus, preventing any possible retaliation against co-parents for not consenting to child participation.

Pregnancy or breastfeeding
Severe psychiatric disorders
Active substance abuse
Unstable medical conditions
Inability to comply with study requirements

Contacts and Locations

Study Contact

Carla S Stover, PhD

CONTACT

2037853486

carla.stover@yale.edu

Principal Investigator

Carla S Stover, PhD

PRINCIPAL_INVESTIGATOR

Yale University

Study Locations (Sites)

Yale

New Haven, Connecticut, 06520

United States

UCONN Health Center

West Hartford, Connecticut, 06119

United States

Collaborators and Investigators

Sponsor: Yale University

Carla S Stover, PhD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-11

Study Completion Date2028-12-31

Study Record Updates

Study Start Date2024-01-11

Study Completion Date2028-12-31

Terms related to this study

Additional Relevant MeSH Terms

Intimate Partner Violence
Child Maltreatment